A Pproximately 67 million Americans suffer from one or more forms of cardiovascular disease (CVD) (AHA, 1989) . Diseases of the heart and blood vessels take a life every 32 seconds, making CVD the leading cause of death in this country. Twenty percent of those who die from CVD are less than 65 years of age, and often are still in the work force. While mortality has declined 24% during the past decade, more than half of those with CVD will eventually die from it.
Cardiovascular disease may be manifest as coronary heart disease, hypertension, rheumatic heart disease, stroke, or congenital heart defects. Acute myocardial infarction (AMI), angina pectoris (AP), and sudden cardiac death (SCD) are important forms of coronary heart disease (CHD) because of the associated mortality and morbidity. About 1.5 million Americans experience myocardial infarction each year, and the death rate exceeds 500,000. About 45% are younger than age 65, and 5% are under age 40. The number of living Americans who have experienced AMI and AP approaches 5 million. Sudden cardiac death due to CHD accounts for more than The costs associated with CHD, including treatment and lost productivity, were estimated at $88.8 billion for 1989 alone. 500 ,000 deaths each year (AHA, 1988) . The costs associated with CHD, including treatment and lost productivity, were estimated at $94.5 billion dollars for 1989 alone (AHA, 1989) . While no single factor has been identified as essential for the development of CHD, a number of attributes have been found to occur more commonly among individuals with CHD (Epstein, 1965) . Extensive prospective epidemiologic studies, such as the Framingham study, and animal experiments have supported the concept of coronary risk factors as precursors and precipitators of CHD (Hilleboe, 1957) , though the mechanisms remain elusive.
Some of these risk factors are modifiable and some are not. However, evidence suggests that the number of risk factors present for individuals influences their chances of developing CHD. Therefore, the concept of risk factor modification is important in reducing an individual's chances of AMI, AP, or SCD. The most significant factors that contribute to an individual's CHD risk are family history, male gender, increasing age, cigarette smoking, hypertension, and elevated blood cholesterol. Other important risk factors are diabetes mellitus, obesity, sedentary lifestyle, and stress.
Stroke is the third largest cause of death in the United States, with a mortality of almost 150,000 persons in 1987 (AHA, 1989) . About 500,000 persons are predicted to suffer strokes in 1990, with 28% of these less than 65 years of age. The age adjusted death rate from stroke has declined over the past decade, but more than 2 million stroke victims are alive and coping with illness and disability.
Risk factors for stroke include hypertension, heart disease, increased red blood cell count, and transient ischemic attacks. Those risk factors that are modifiable should be the focus of a risk factor reduction regi-men to prevent or delay the onset of disease or slow disease progression. The occupational health nurse should be knowledgeable about these risk factors to assist those in the work force in adopting a healthy lifestyle.
CIGARETTE SMOKING
More than 50 million Americans smoke. The prevalence of cigarette smoking in the United States decreased from 33.5% to 29.1% of the population between 1979 and 1987 (Centers for Disease Control, 1989a) , partially because of antismoking campaigns (Warner, 1989) . Although fewer people are smoking, the number of cigarettes consumed per smoker has increased.
The number of women who smoke (23.8%) has declined at a less rapid rate than the decline rate for the number of men who smoke (29.5%). The number of female smokers may some day surpass the number of male smokers . Young women are the group with the slowest decline in cigarette smoking (Warner, 1989) .
Smoking contributes to more than 300,000 deaths per year from passive and active exposure to tobacco and toxins (Henningfield, 1988) . In the black adult population, smoking contributes to increased mortality in excess of mortality in white populations through an interaction of six major risk factors (smoking, systolic blood pressure, cholesterol level, bodymass index, alcohol intake, and diabetes), family income, and additional unknown factors (Otten, 1990) .
Use of smokeless tobacco is increasing, with an estimated 10 million to 22 million users in the United States, 3 million of whom are under age 21 (Gross, 1988) . Smokeless tobacco use permits absorption of large amounts of nicotine, with systemic effects on the cardiovascular system.
Evidence Linking Smoking to Coronary Heart Disease
Cigarette smoking is the primary risk factor for sudden cardiac death, with 2 to 4 times the risk in smokers as in nonsmokers (AHA, 1988) . In men and women, smoking doubles the risk of stroke and myocardial infarction (Buhler, 1988) . In the past, smoking was thought to be "significantly associated" with the development of CHD. Smoking is now known to have a causal relationship with CHD (Warner, 1989) . It also is linked with emphysema, esophageal cancer, and low birthweight babies.
The over 4,000 chemicals in tobacco predispose the cardiovascular system to increased clotting, atherogenesis, tachycardia, spasm of vessels, and inadequate tissue oxygenation (Cohen, 1988) . Absorbed nicotine has a sympathomimetic effect, resulting in tachycardia and vasoconstriction (Gross, 1988) .
Recommendations
In 1980, the U.S. Department of Health and Human Services published national objectives to be attained by 1990 (U.S. DHHS, 1980) . The four objectives (Shopland, 1987) Other than the first objective, survey data indicate that the objectives will probably be met by this year (Shopland, 1987) . National objectives for the year 2000 (due to be introduced this month) include further recommendations for smoking cessation and education about health risks of smoking (Centers for Disease Control, 1989b) .
The most obvious alternative to reducing health hazards induced by smoking is smoking cessation. Although the large number of nurses who smoke are probably representative of the general population (Haverty, 1986) , nurses as health professionals should assist colleagues with the support and strategies necessary to stop smoking.
At the worksite, the occupational health nurse is a key person to assist the employees with reducing or curbing smoking. During routine health assessments, or with the presentation of anyone of the risk factors for CVD, the nurse should inquire about the entire spectrum of risk factors for CVD.
The physical examination should include height and weight, blood pressure assessments (ambulatory measurements are more accurate than isolated resting measurements), and assessment of the heart, lungs, and peripheral circulation. Laboratory data on cholesterol and glucose levels provide further insight into risk factors.
The client who smokes should be encouraged to stop smoking. Planning in collaboration with the client's individual needs and lifestyle, along with specific follow up appointments to gauge progress with the modifiable risk factors, should ensure a higher probability of success than planning without the client or making no follow up appointments.
The nurse should work closely with employees to assess their level of knowledge about smoking and its adverse effects. Listening to the fears and worries about smoking and attempts to reduce or stop smoking should help the client learn that the nurse is supportive in the behavior change, and will provide opportunities for the nurse to refute myths or ' encourage employees in their efforts.
Educational literature and pamphlets on smoking cessation are available from the American Heart Association and American Cancer Society. Numerous programs are available to assist the employees in their attempts to reduce or to stop smoking.
The nurse can assist in finding a method that is most meaningful and helpful for the individual.
Research (Benowitz, 1983) indicates that changing to a low yield cigarette brand may not reduce smoking risks, because the smoker compensates by overinhaling. Overinhaling also may negate any reduction in risk realized by reducing the number of cigarettes the smoker normally consumes (Benowitz, 1986) .
Over the past 20 years, many treatment methods have been tried, including group treatment, hypnosis, acupuncture, and aversion therapy, generally with an abstinence rate of 10% to 25% at the end of 1 year (Werther, 1988) . In groups with higher educational levels, smoking cessation is occurring at a faster rate (Pierce, 1989) . Specific interventions need to be directed toward clarifying the information in the 1990 objectives for laypersons, and toward helping blacks and young women to stop smoking.
In the future, public policy may place further restrictions on smoking and on enforcement of clean air laws. Encouraging smoking cessation in a supportive manner must become a necessary part of care in health promotion efforts of the occupational health nurse.
HYPERTENSION
The most prevalent form of CVD is hypertension, occurring in 57 million Americans in the 1980s (Wenger, 1988) . Hypertension is a prominent risk factor for CVD; hypertensive individuals have a higher prevalence of additional cardiovascular risk factors of hypercholesterolemia, diabetes mellitus and glucose abnormalities, obesity, and left ventricular hypertrophy (Kaplan, 1988) .
Complications of hypertension include damage to the heart, renal organs, or vasculature in conditions of atherothrombotic stroke, hemorrhagic stroke, sudden cardiac death, coronary heart disease, heart failure, renal failure, peripheral vascular disease, and aortic dissection (Oliver, 1987) .
Statistics indicate that 12% of the population between ages 18 and 74 has mild to moderate hypertension (systolic 140 to 159 mm Hg), while 17.7% of adults have severe hypertension (systolic> 159 mm Hg) (Chronic disease reports, 1989c). In 1986, mortality from hypertension in this country was 30,100 deaths (AHA, 1988) .
Black Americans have a one third greater chance of having hypertension than whites (AHA, 1988; Kelly, 1989) . Black persons also suffer from more renal vascular effects of the disease than white persons (Messerli, 1988) .
Ninety percent of individuals with high blood pressure in the United States have essential hypertension (hypertension of unknown origin) (Messerli, 1988; Weiss, 1988) . In the remaining individuals for whom a cause is known, contributing illnesses may include coarctation of the aorta, pheochromocytoma, primary aldosteronism, Cushing's reflex, or renal causes of hypertension (Gifford, 1989 ).
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Evidence Linking Hypertension to Coronary Heart Disease
Hypertension traditionally has been recognized as a major risk factor for stroke, SCD, and ischemic heart disease, particularly CHD (Grundy, 1987; Harris, 1988; Kaplan, 1989; Schieken, 1988; Shapiro, 1988) . Diastolic hypertension is implicated in 20% of the incidence of CHD (Schieken, 1988) with an increased risk of CHD also reported in persons with isolated systolic hypertension (Chobanian, 1988) . Kelly (1989) reports a growing concern that morbidity data relative to the complications of hypertension have not been well reported, studies are lacking appropriate randomization of samples, and findings are often inaccurate and unreliable.
Recent studies have indicated that evidence linking hypertension directly with CHD events or demonstrating that mortality from CHD is decreased by reducing elevated blood pressure to normal levels is lacking (Dzau , 1988; Middeke, 1988; Schieken, 1988) . Some complications of hypertension may be more amenable to treatment than others. Interventions which prevent organ damage in vulnerable tissues (hemorrhagic stroke, heart failure, renal failure, and aortic dissection) may be more effective than interventions to prevent complications in already atherosclerosed tissue, such as CHD, sudden cardiac death, atherothrombotic stroke, and peripheral vascular disease (Oliver, 1987) .
In one study, a group of hypertensive men with an abnormal resting electrocardiogram died of sudden death while on diuretic therapy in the special intervention group (Messerli, 1988) . The exact reason for the deaths is unknown, but some of the men had risk factors of smoking and elevated cholesterol levels. Possible explanations for these latest findings about hypertension include: 1) hypertension and CHD may not be causally related, 2) concomitant hypertension in persons with coronary artery disease may lead to signs of ischemia, and 3) drug therapy for hypertension may have side effects which worsen other risk factors for CHD (Dzau, 1988) .
Some of the antihypertensive medications affect glucose and lipid metabolism and may actually increase total cholesterol and low density lipoprotein levels, which are clearly and directly associated with CHD. Diuretic therapy may deplete potassium reserves, contributing to the development of cardiac dysrhythmias in ischemic individuals.
Increasingly, it is clear that hypertension has a complex relationship with other risk factors in the development of atherosclerosis (Kannel, 1987a) . Coexisting risk factors of smoking, glucose intolerance, and hyperlipidemia, together with hypertension, increase the mortality in persons with CHD (Chobanian, 1988) .
Other studies report associations with hypertension and CHD development from risk factors of left ventricular hypertrophy, total peripheral resistance, and other structural and functional changes in vessel walls (Egan, 1988; Leenen, 1989) . Some health conditions (e.g., obesity) contribute to ventricular enlargement; obesity is also a risk factor for the development of CHD (Tsai, 1988) . Some studies are indicating a neurogenic contribution to the development of CHD (Eliot, 1988) .
Recommendations for Risk Modification
Elevated blood pressure is generally based on two or more measurements, on two or more occasions, in which the systolic blood pressure (SBP) is 140 mm Hg or greater, and/or the diastolic blood pressure (DBP) is 90 mm Hg or more.
Mild hypertension (Table) is a DBP of 90 to 104 mm Hg, moderate hypertension is a DBP from 105 to 114 mm Hg, and severe hypertension is a DBP 115 mm Hg or greater (National High Blood Pressure Education Program, 1984) . Isolated systolic hypertension refers to SBP elevations of 160 mm Hg or greater, without elevated DBP. The Figure has guidelines for frequency of monitoring and referral of persons with elevated blood pressures.
Interest is growing in home monitoring of blood pressure, and in 24hour ambulatory blood pressure monitoring. For years, the "white coat" effect presumed that some persons may have elevated blood pressures in clinic environments over home environments (Stanek, 1989) . While this effect can be seen in some individuals, recent literature reports that blood pressure may have a circadian influence, with variations that range from higher levels during times of work, psychological stressors, and activity, and lower levels during rest and sleep (Weber, 1989) .
Whether a casual or screened blood pressure may be indicative of an individual's usual or peak blood pressure, and to what extent the casual blood pressure should guide decisions in management of hypertension, is controversial. As a result, interest in 24-hour ambulatory blood pressure monitoring is growing, particularly in evaluating individuals who are borderline hypertensives (Krakoff, 1988; Lavie, 1988; Mancia, 1988; Pickering, 1988; White, 1989) .
Stepped care for hypertension, which began in the 1970s (Frohlich, 1988) , has been broadened by the 1988 Report of the Fourth Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure to increase the flexibility for clinicians in the use of the usual and newer pharmacologic agents for treatment of hypertension (Table) . This report also encourages more client involvement in treatment, especially with regard to nonpharmacologic mechanisms of treatment, considers the relationship of treatment with other CHD risk factors, and takes into account more issues of care, e.g., quality of life and costs of care.
The goal of antihypertensive therapy is to achieve and maintain a long term blood pressure which is less than 140/90 mm Hg, with minimal, if any, side effects Joint National Committee, 1988 . Nonpharmacologic treatment of hypertension is often the first mode of therapy, particularly in isolated systolic hypertension, and includes risk factor modification, control of weight, sodium restriction, and moderation of alcohol consumption.
Several special populations with hypertension are discussed in the 1988 report Joint National Committee, 1988 with considerations for therapy: blacks and other Joint National Committee, 1988 . Blacks and older persons respond better to diuretics or calcium antagonists than to beta blockers or ACE inhibitors Joint National Committee, 1988 . White persons often respond well to beta blockers. Combinations of dru gs often produce a desired resp on se in the blood pressure (Moser, 1989; Ruoff, 1989) .
All ant ihyperte nsive medications have some side effects. Beta blockers may decrease exercise tolerance , and ce ntrally acting alpha blockers may impair mental alertness Joint N ational Committee, 1988 . Some agents may alter lipid metabo- (1988) .
Recommendations are that nonfasting serum cholesterol screening should be done on all adults of 20 composed of triglyceride and contain 10% to 15% of the total serum cholesterol.
Evidence Linking Cholesterol to Cardiovascular Diseases Evidence strongly supports a direct relationship between total serum cholesterol and LDL cholesterol and CHD (Arntzenius, 1985; Martin, 1986; National Cholesterol Education Program, 1988; ). In addition, elevated lipids and cholesterol are secondary risk factors for stroke because they increase the risk for heart disease, a primary risk factor for stroke (AHA 1989) . Although the adverse effects of cholesterol were quantified as early as 1961 in the Framingham Study, the scientific evidence regarding the relationship between cholesterol and heart disease remained controversial.
In 1984, a randomized, placebo controlled double blind primary prevention clinical trial using a lipid lowering drug, cholestyramine, in middle aged men demonstrated that each 1% decrease in serum cholesterol level resulted in a 2% reduction in CHD (Lipid Research Clinics Program, 1984) . Other clinical trials such as the Multiple Risk Factor Intervention Trial (MRFIT), Oslo heart study, and the World Health Organization clofibrate trial similarly have demonstrated the relationship between cholesterol lowering and the incidence of CHD (Rifkind, 1987) . Thus, epidemiologic studies as well as clinical trials conducted in many populations support the contribution of cholesterol to CHD (Gordon, 1989; Tyroler, 1987 Tyroler, ). 1986 ). Although mean serum cholesterol levels have declined in this country from 217 mg/dL for men and 223 mg/dL for women in the period from 1960 to 1962, to 211 mg/dL for men and 215 mg/dL for women in the time between 1976 and 1980, increasing efforts are needed to reduce blood cholesterol levels (National Center for Health Statistics, 1986) . Over one quarter of the population (28.5% of the women and 24.9% of the men) is estimated to have blood cholesterol levels greater than 240 mg/dL (U.S. DHHS, 1989) .
Low density lipoproteins (LDLs), the major atherogenic class of lipoproteins, constitute 60% to 70% of the total cholesterol. LDL cholesterol is the actual target of cholesterol lowering efforts because it contributes to the buildup of cholesterol in the arteries and promotes CVD when the concentration of LDL exceeds 125 mg/dL and total cholesterol is over 200 to 220 mg/dL (Doran, 1984; Levy, 1981) .
High density lipoproteins (HDLs) contain 20% to 30% of the total cholesterol and are thought to be effective in removing cholesterol from arterial walls, thus exerting a protective effect. The other class of lipoproteins, the very low density lipoproteins (VLDL), are largely HYPERCHOLESTEROLEMIA Individuals with elevated cholesterol levels have a threefold greater risk of developing CHD than individuals with normal cholesterol levels, as well as increased risks for stroke and hypertension (AHA, 1989; Anderson, 1987 ; Stamler, Figure: Individualized step-care therapy for hypertension. For some patients, nonpharmacologic therapy should be tried first. If blood pressure goal is not achieved, add pharmacologic therapy. Other patients may require pharmacologic therapy initially. In these instances, nonpharmacologic therapy may be a helpful adjunct. ACE indicates angiotensin-converting enzymes; asterisk, drugs such as diuretics, B-blockers, calcium antagonists, ACE inhibitors, a-blockers, centrally acting a 2-agonists, rauwolfia serpentina, and vasodilators.
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Control Other Cardiovascular Risk Factors lism, and may actually increase levels of low density lipoproteins or total cholesterol. Many drugs impair sexual function. Costs of medications vary, and prohibitive costs may adversely affect compliance. The more expensive medications are not necessarily the best (Neal, 1989) . Antihypertensive therapy should address the needs of the individual, including perceptions of quality of life (Kinney, 1988) .
One should avoid labeling a person as hypertensive in cases of borderline hypertension or unconfirmed assessment. The psychological distress to an individual from the "labeling effect" can result in increased absenteeism from work, marital and home dissatisfaction, worrying about health, and loss of control (Wenger, 1988) . Emphasize the positive aspects of control, such as weight control, the effects of exercise, and the individual's involvement in a plan for better health.
years of age or older at least every 5 years. Individuals with levels less than or equal to 200 mg/dL should be given risk reduction educational materials and tested again in 5 years. Those with higher levels should have a repeat test in 1 to 8 weeks. The average of the two tests is used to make further clinical decisions if the level is within 30 mg/dL of the first result. If not, a third test should be obtained and the average of the three tests used.
Individuals with borderline high cholesterol levels (200 to 230 mg/ dL), confirmed by two or more readings, who do not have CHD or two other risk factors are given diet reduction instruction and retested in 1 year. Risk factors include male sex, family history of premature CHD, cigarette smoking, hypertension, diabetes mellitus, severe obesity, cerebrovascular or peripheral disease, and low HDL cholesterol.
Individuals with high cholesterol (greater than 240 mg/dL) and borderline (200 to 239 mg/dL) cholesterol who have CHD or two risk factors should be tested for LDL cholesterollevel and begin diet therapy.
The guidelines propose a desirable cholesterol level of 200 mg/dL, and that diet reduction is the primary treatment for hypercholesterolemia (National Cholesterol Education Program, 1988) . Step 1 of diet therapy requires that total daily fat intake equal less than 30% of calories, cholesterol less than 300 mg/dL, and saturated fatty acids less than 10%. Serum cholesterol is monitored at 4 to 6 weeks and 3 months after the diet is begun.
Step 2 is begun if the cholesterol level is not reduced with the Step 1 diet. Daily fat intake is restricted to less than 30% of calories, cholesterol intake less than 200 mg/dL, and saturated fat less than 7%. Except in persons with very high LDL cholesterol levels, a minimum of 6 months of diet therapy is recommended before using drug treatment to reduce cholesterol. After initiation of diet and/or drug therapy, long term monitoring is indicated.
DIABETES MELLITUS
Diabetes Mellitus (OM) also has been identified as an independent risk factor for the development of CVD (American Diabetes Association [ADA], 1989; Kannel, 1979; Kannel, 1985; Pan, 1986) . The prevalence of macrovascular complications such as CHD, cerebrovascular disease, and peripheral vascular disease is 2 to 4 times higher in diabetics compared to nondiabetics (ADA, 1989) .
As the severity of OM increases, the risk of CHD increases, with persons with insulin-dependent diabetes mellitis (100M) experiencing the highest risk (Lemp, 1987) . The ADA (1989) reported that persons with 100M without renal disease have four times the risk of CVD compared with nondiabetic individuals of the same age even in the absence of other major risk factors, and with the onset of renal disease, the risk of CVD increases to 12-fold.
In addition, the relative impact of diabetes on CVD morbidity appears to be greater for women than men (Kannel, 1985; U.S. DHHS, 1987) . For women, asymptomatic hyperglycemia also is an independent risk factor for CHD (Pan, 1986) . Diabetes is associated with an increased risk of CVD mortality, in particular for women (Pan, 1986; U.S. DHHS, 1987) . In the Framingham study, the relative risk of CVD death was almost doubled in men but more than tripled for women with diabetes even in the absence of other major risk factors (Kannel, 1979) .
Other cardiovascular risk factors are more likely to be found in diabetics than in nondiabetics. Persons with non-insulin dependent diabetes mellitus (NIDDM) are more likely to be hypertensive and 60% to 85% are obese (ADA, 1989; U.S. DHHS, 1987) . In the Framingham study, HDL cholesterol was consistently lower and VLDL cholesterol was elevated in persons with diabetes, especially in women (Kannel, 1985) .
Decreasing the impact of CVD morbidity and mortality for individuals with diabetes may necessitate not Russo et al only control of hyperglycemia but a comprehensive program of risk factor reduction (ADA, 1989) . In particular, weight reduction may be of benefit because of its favorable effects on blood pressure, glucose tolerance, and lipid profiles (Kannel, 1985) .
OBESITY
Excessive weight is common in the United States. The second National Health and Nutrition Examination Survey (NHANES 11), conducted from 1976 to 1980, found that approximately 34 million adults, or 26% of the non-institutionalized, civilian population, were overweight (Centers for Disease Control, 1989d, Van Itallie, 1985) . Weight greater than 20% of ideal body weight is generally considered to constitute a health hazard (National Institutes of Health Consensus Development Panel on the Health Implications of Obesity [NIH Panel], 1985) .
Obesity is associated with increased relative risk for CHD, including AMI and SCD (CDC, 198ge; Hubert, 1983) . The Framingham study found the heaviest groups of males and females experienced 2 and 2.4 times, respectively, the risk of CHD compared with the leanest groups of males and females for the under 50 age group (Hubert, 1983) .
Obesity is associated with several CVD risk factors including hypertension, hypercholesterolemia, decreased HDL cholesterol levels, and diabetes and glucose intolerance (Kannel, 1987a; \an Itallie, 1985) . In addition, studies have demonstrated a direct association between weight changes and changes in CVD risk factors (Ashley, 1974; Borian, 1986; Kannel, 1987a; Noppa, 1980) . The NHANES II data revealed increased risks for hypertension, hypercholesterolemia, and diabetes in overweight persons aged 20 to 75 years, with the 20 to 44 year age group showing even higher relative risks. The overall relative risk for hypertension in overweight persons was 2.9; however, for the 20 to 44 year age group, the relative risk was 5.6. The overall risks for hypercholesterolemia and diabetes were 1.5 and 2.9, respectively, but for the 20 to 44 year age group the relative risks increased to 2.1 and 3.8 (~n Itallie, 1985) .
Obesity was found to be an independent predictor of hypertension in one study (MacMahon, 1984) with up to 30% of the hypertension observed in the study group attributed to obesity. For the subgroup of men less than 45 years of age, the proportion of hypertension which could be attributed to obesity doubled to 60%.
In the Framingham offspring study, women in their 40s who were markedly obese had seven times the risk of developing hypertension compared to their lean counterparts (Garrison, 1987) . Kannel (1987a) noted that about 70% of the hypertension which developed in the Framingham offspring sample during an 8 year follow up period was estimated to be attributed to weight gain.
Obesity is also associated with decreased levels of HDL cholesterol and increased levels of VLDL cholesterol. However, weight reduction has been associated with increased HDL levels even with concurrent hypertriglyceridemia and with lowering of total serum cholesterol (Bruno, 1983; Carmena, 1984; Garrison, 1980) . The role of obesity as an independent predictor of CHD is less clear. Results from the Framingham and Manitoba studies supported a direct linear association, independent of other risk factors (Hubert, 1983; Rabkin, 1977) . The Framingham study found this relationship stronger for females than for males (Hubert, 1983) .
Other studies have demonstrated different patterns of association, and still others have shown no association (Barrett-Connor, 1985) . Recent studies suggest that the distribution of weight, in particular increased abdominal fat, rather than the degree of obesity may be more predictive of CVD risk (Bray, 1989; NIH Panel, 1985) . Itallie (1985) noted the differential impact of obesity on the younger part of the NHANES II sample, suggesting that overweight sustained in early life is more hazardous. The NIH Panel noted the relative impact of obesity on all-cause mortality in persons under 50 years of age and suggested that special attention should be focused on weight reduction in younger individuals.
PHYSICAL INACTIVITY
Lack of exercise or physical inactivity has been implicated as a key factor in development of coronary heart disease and a secondary risk factor for stroke (AHA, 1989; Ryan, 1988; U.S. DHHS 1989) . Because a large proportion of the U.S. population is inactive and the relative risk for inactivity (1.9) is similar to that of cigarette smoking, hypertension, and cholesterol, improved exercise patterns may have tremendous impact on reducing the morbidity and mortality associated with cardiovascular disease.
Only 8% of the American population engages in vigorous exercise 3 or more days a week, which produces a cardiorespiratory training effect (Caspersen, 1986) . Only another third of the population engages in exercise 3 or more days of the week at any level of intensity (CDC, 1989d; U.S. DHHS, 1989) . In addition, sedentary lifestyles are common among women, older individuals, and socially disadvan raged groups.
Empirical evidence of the relationship between physical activity and cardiovascular disease continues to accumulate. Vigorous individuals have been found to be at lower risk for CHD, hypertension and stroke (Blair, 1984; Morris, 1973; Paffenbarger, 1984; 1978; Powell, 1987; Shepard, 1986; Siscovick, 1985) . Not only does vigorous activity lower serum cholesterol, triglycerides, blood pressure and decrease body fat, but it also increases concentrations of HDLs which are thought to protect individuals from atherosclerosis (Cooper, 1976; Cullinane, 1982; Lopez, 1974; Seals, 1984) .
In animal models, physical activity has been found to reduce coronary vasospasm, and increase coronary collateral development, the caliber of epicardial coronary arteries, and the resistance to ventricular fibrillation (Billman, 1984; Bove, 1985; Kramsch, 1981; Noakes, 1983) .
Research on the relationship between physical activity and cardiovascular disease has been criticized for inadequate measurement of the physical activity variable, sampling bias, and problems with recall data. No randomized controlled experiments have been conducted because of problems with adherence, cost, and size of sample. Nevertheless, experts believe that data consistently support the conclusion that physical activity is inversely related to the incidence of cardiovascular disease (Powell, 1987) .
Exercise Recommendations
Guidelines to modify physical activity levels have been proposed by the American College of Sports Medicine (1986) . Aerobic exercises such as walking, running or jogging, swimming, bicycling, cross country skiing, rowing, and others should be performed 3 to 5 times per week preferably with a day of rest following each day of exercise. Each exercise session should include a 5 to 10 minute warm up period, a minimum of 20 to 30 minutes devoted to the aerobic conditioning activity, and 5 to 10 minutes for cool down. The intensity of the exercise should be sufficient to raise the heart rate to 60% to 85% of the heart rate predicted for that age.
Individuals beginning an exercise program should gradually progress the duration and intensity of the exercise until recommended levels of aerobic activity are reached. Because of recent evidence that health benefits also accrue for physical activity of moderate intensity, the American public should be encouraged to participate in both moderate and vigorous exercise (CDC, 1989f; Leon, 1987.) 
WOMEN
CHD is the number one killer of women in America . Women account for 250,000 of the total of 540,000 annual deaths attributed to cardiovascular disease, and 23% of these deaths are due to CHD. Age adjusted stroke death rates are similar for white males and females and are greater among black females than among white males (AHA, 1989) . Despite significant cardiovascular mortality among women, little attention has been given to the study of risks among women.
Few studies of women and cardiovascular risks have been conducted and risks have been underestimated in women. For example, the risk factor of obesity in women has been underappreciated until a recent study reported that 40% of all heart disease among women was related to obesity (Manson, 1990) .
The lack of attention to risk of cardiovascular disease in women may be due to the commonly held view that women seem to be protected against cardiovascular disease until menopause. The incidence of CHD is 2 to 4 times higher in men than in women until age 70, after which time the incidence becomes the same (Kannel, 1976; Murdaugh, 1986; National Center for Health Statistics, 1983) .
The Framingham study demonstrated that a two fold increase in CHD occurs in postmenopausal women and some investigations have reported a positive association be-tween early natural or surgically induced menopause and CHD (Bengtsson, 1981; U.S. DHHS, 1987) . Female sex hormones are thought to have an indirect effect on CHD because blood pressure and LDLs increase in women after menopause (Carlson, 1985; Elveback, 1986) . Indeed, the average cholesterol level of women ages 45 to 55 exceeds men of that age, and women who smoke experience earlier menopause than nonsmoking women (U.S. DHHS, 1987) .
Estrogen replacement therapy for postmenopausal women has been suggested to prevent or postpone the development of CHD. While in some studies estrogen has been found to protect women from CHD, in other studies subjects receiving estrogen replacement therapy experienced an increased incidence of CHD (The Coronary Drug Project, 1973; Murdaugh, 1986) .
Further research is needed to investigate the effect of female sex hormones in preventing coronary artery disease.
Another explanation for the decreased incidence of cardiovascular disease in women less than age 70 pertains to the roles of women in society. Women had been thought to be protected from heart disease, hypertension, and strokes because they were not gainfully employed in the work world and did not experience occupational stress.
With the majority of women now working outside the home, role conflict and role overload among women have reached excessive proportions. Working women spend more time and effort on home and family obligations than men, and therefore may have two full time jobs, one at home and one outside the home. Higher rates of CHD were reported in the Framingham study among working women with three or more children than among working women with no children or housewives with three or more children (Haynes, 1980) . Further research is needed to ascertain whether women's movement into the labor force will contribute to an Russo et al increased incidence of cardiovascular disease.
PSYCHOSOCIAL FACTORS
Although several biological risk factors have been well established as risk factors for CHD, the role of psychological and social influences on CHD risk is less certain (Criqui, 1986; Kannel, 1987a) . Several factors for which research data are available are discussed.
Type A Behavior
Type A behavior is characterized by a pattern of responses to environmental stimuli that includes harddriving competitiveness, aggressiveness, and a chronic sense of time urgency (Matthews, 1986) . Studies examining Type A behavior and risk of CHD have not shown consistent associations between global Type A behavior and subsequent CHD (Matthews, 1986) .
In the Framingham study, Type A behavior was associated with a twofold increase in CHD risk for men and women age 45 to 60 years, although for men only those in whitecollar jobs showed increased risk (Haynes, 1980) . Analysis of the Framingham data suggested that the association between Type A behavior and CHD was most evident when other CHD risk factor levels were present. The Western Collaborative Group Study also found a two-fold increase in CHD risk for Type A as compared to Type B males in the sample of white, middle class men studied (Rosenman, 1975) .
In contrast, the Honolulu Heart Program did not show an association between incidence of CHD and Type A behavior in males of Japanese ancestry, but both the incidence of CHD and Type A behavior were low compared with the Framingham and other population based studies of white males (Cohen, 1985) . Type A behavior does appear to have some predictive value for future development of CHD in initially healthy white males (Matthews, 1986 ).
However, insufficient evidence exists to support a similar association for women or non-white men, primarily due to a lack of studies on these population groups (Matthews, 1986) . Recent research has focused on hostility and expression of anger, components of Type A behavior, as more predictive of CHD than global Type A behavior but further studies are needed (Williams, 1987) .
Stress \arious studies have examined the role of social or occupational stress on the incidence of CHD, although difficulties arise in comparing studies due to differing definitions of "stress."
Experimental studies showed socially stressed monkeys were more likely to develop atherosclerosis than nons tressed monkeys even when both groups were on a low cholesterol diet (Kaplan, 1983) . Blue collar male workers experiencing subjective and objective measures of occupational stress had higher LOLl HDL ratios than their unstressed counterparts, and the number of negative recent life events and chronic interpersonal difficulties were significant discriminators between blue-collar male workers who had had a myocardial infarction and controls (Siegrist, 1988; .
It had been suggested that as women entered the work force, occupational stress would lead to an increased incidence of CHD (U.S. DHHS, 1987) . However, results from the Framingham study did not support this hypothesis, and the San Antonio Heart Study reported differences in lipid profiles favoring employed women over homemakers for risk of CHD, particularly for women in white collar jobs (Haynes, 1980; Hazuda, 1986; U.S. DHHS, 1987) .
Lack of social support also has been associated with increased cholesterol levels in unemployed men and was a discriminator of blue collar workers who had experienced a myocardial infarction compared with controls (Gore, 1978; Siegrist, 1987) . Kuller (1984) noted strong inverse relationship between socioeconomic class and the distribution of risk factors for CHD. When level of education is used as an indicator of social class, studies have demonstrated an inverse relationship between education and CVD lifestyle related risk factors such as smoking, level of physical activity, and dietary habits (Jacobsen, 1988; Liu, 1982) . Liu (1982) recommended targeting less educated segments of the population for risk factor reduction.
Social class
OTHER CHO RISK FACTORS Alcohol
Alcohol consumption is associated with CVD risk, in particular with hypertension (Dyer, 1981; MacMahon, 1984) . Studies have shown a U-shaped pattern of association, with heavy consumption (usually defined as more than three drinks a day) associated with increased CHD risk and mortality compared with moderate or no consumption, and moderate consumption (defined as one or two drinks a day) associated with a lower incidence of CHD than no consumption (Dyer, 1981; Kannel, 1987a; Klatsky, 1981; MacMahon, 1984; U.S. DHHS, 1987) .
One drink is usually defined as 12 ounces of beer, 4 ounces of wine, or 1.5 ounces of hard liquor (U.S. DHHS, 1987) . The mechanism for the apparent protective effect of moderate alcohol consumption is unclear, although effects on blood lipid levels or the coagulation system have been suggested (Criqui, 1986; Kannel, 1987a) .
The 1988 Report of the Joint N ational Committee on Detection, Evaluation, and Treatment of High Blood Pressure recommends that individuals with hypertension who do drink should do so in moderation. The U.S. DHHS (1987) also recommends moderation for individuals who consume alcohol.
Oral Contraceptives
Oral contraceptive use is associated with increased CVD risk. Oral contraceptives affect lipid metabo-lism and can produce elevations in blood pressure and decrease glucose tolerance U.S. DHHS, 1987) .
Women who use oral contraceptives have a risk of AMI up to 4'12 times that of women who do not use oral contraceptives. For women who both smoke and use oral contraceptives, the risk for AMI may be as high as 39 times that of non-smoking women who do not use oral contraceptive (Rosenberg, 1980; U.S. DHHS, 1987) . Among oral contraceptive users the risk of hypertension is estimated to be 3 to 6 times that of nonusers and for oral contraceptive users who smoke, the risk of stroke may be up to 22 times more likely than for nonusers who do not smoke U.S. DHHS, 1987) . Clinicians should not only screen to detect CVD risk factors in oral contraceptive users but should suggest interventions to reduce or eliminate those risk factors ).
Family History A strong family history of CHD generally is considered a risk factor for CHD. Two recent prospective studies provide support for the role of family history in CVD risk. Even after adjustment for demographic and major CVD risk factors, family history remained a significant predictor of CVD in a high risk population in Utah (Hopkins, 1988) . In the Framingham study, a 30% increase in the 'risk for CAD was associated with death due to CAD in one or both parents (Schildkraut, 1989) .
In reviewing genetic aspects of CHD, Neufeld (1983) noted that while some of the familial risk pattern is probably due to shared environmental factors, evidence supports differences in genetic susceptibility to risk factors. For example, some studies have demonstrated differences in patterns of risk factors and associated incidence of CHD between blacks and whites in the U.S. (Curry, 1984; Gartside, 1984; Van Itallie, 1985) . Other studies have linked genetic factors to lipid profiles, hypertension, and diabetes and the observed differences in male and female patterns of CVD morbidity and mortality may reflect sexbased differences in CHD susceptibility (Neufeld, 1983) .
SUMMARY
In summary, CVD risk is multifactorial. Occupational health nurses should use a multifacted approach in assessing employees for risk factors, planning intervention programs aimed at risk reduction, and in evaluating the effectiveness of interventions which are implemented.
Occupational health nurses are in a unique position to assist employees with risk factor modification. For those employees in the predisease stage in which CVD is not yet detected, primary prevention strategies can be used. These strategies include screening programs to detect risk factors and education to alert employees to their individual risk profile and the importance of a healthful lifestyle in reducing risk. For employees in whom clinical signs of CVD are already evident, secondary prevention strategies can assist them to adhere to therapies designed to slow disease progression, prevent complications, and minimize morbidity.
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